Sophie Cui
Biomarker IVD, Director Gilead Sciences
Seminars
Wednesday 12th November 2025
Dx Strategy: Strategic Planning to Enable China Joining Global Clinical Trials with Simultaneous Filing Intent
9:00 am
- Showcasing study kick off efforts and timeline in China including HGR related information
- Reviewing Dx development strategy to align with global and to support CN trial
- Discussing high level drug filing plan with Dx being a component
